InsiderTrades

Form 4 for DNA Ginkgo Bioworks Holdings, Inc.

Accepted 2025-05-22 00:00:00 ET · period of report 2025-05-20 · accession 0001127602-25-015300 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-05-22 2025-05-21 DNA Coen Steven P. See remarks S - Sale+OE $7.59 -346 9,216 -4% -$2,626
DM 2025-05-22 2025-05-20 DNA Coen Steven P. See remarks M - OptEx — +743 9,562 +8% —
DM 2025-05-22 2025-05-20 DNA Coen Steven P. See remarks M - OptEx — -743 5,315 -12% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-05-21 S D 346 $7.59 9,216 D — —
2 Common Class A Common Stock 2025-05-20 M A 587 — 9,406 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
3 Common Class A Common Stock 2025-05-20 M A 156 — 9,562 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
4 Derivative Restricted Stock Units 2025-05-20 M D 587 — 14,101 D — · — to — 587 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F3) The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.
5 Derivative Restricted Stock Units 2025-05-20 M D 156 — 5,315 D — · — to — 156 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F4) The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.